Pyrazinib is a novel inhibitor of angiogenesis and metabolism of oesophageal adenocarcinoma (oac) radioresistance, significantly inhibiting the secretion of il-6, il-4, il-8 and il-13 cytokines from in oac radioresistant cells
Molecular Weight:
198.22
CAS Number:
[200417-97-6]
Formula:
C12H10N2O
Target:
Others|||Interleukin
T70001
* VAT and and shipping costs not included. Errors and price changes excepted